Summary
We present seven cases of Pompe disease (McKusick 232300; glycogen storage disease type II; acid maltase deficiency) from Greece. The onset of symptoms varied from early childhood to late adulthood, and the patients had quite variable duration of disease. All but one of them had muscle weakness and all had mildly to highly elevated serum creatine kinase. The diagnosis in all cases was confirmed by the finding of acid α-glucosidase (EC 3.2.1.3/20) deficiency in cultured skin fibroblasts. Thirteen mutant alleles were identified and nine different pathogenic mutations were encountered. Four were new: c.2071_2072insAGCCG leads to frameshift and total loss of function; c.1856G > A (p.Ser619Asn) leads to 90–95% loss of function; and the splice-site mutations c.1552−3C > G and c.2331+4A > G reduce the number of correct splicing events by more than 90%. The splice-site mutation c.-32-13T > G (IVS1-13T > G) was encountered four times and seems equally common among Greek and other caucasians. The other mutations: c.925G > A (p.Gly309Arg), c.[307T > G; 271G > A] (p.Cys103Gly; Asp91Asn), c.271del and c.1655T > C (p.Leu552Pro) have been reported earlier. Our study highlights the heterogeneity of Pompe disease in Greece and provides tools for diagnosis and carrier detection.
Similar content being viewed by others
Abbreviations
- CK:
-
creatine kinase
- ECL:
-
enhanced chemoluminescence
- PCR:
-
polymerase chain reaction
- RT-PCR:
-
reverse transcription polymerase chain reaction
- SDS-PAGE:
-
sodium dodecyl sulphate–polyacrylamide gel electrophoresis
References
Ausems MG, Lochman P, van Diggelen OP, Ploos van Amstel HK, Reuser AJ, Wokke JH (1999) A diagnostic protocol for adult-onset glycogen storage disease type II. Neurology 52: 851–853.
Bodamer O, Haas D, Hermans M, Reuser A, Hoffmann G (2002) l-Alanine supplementation in late infantile glycogen storage disease type II. Pediatr Neurol 27: 145.
Boerkoel CF, Exelbert R, Nicastri C, et al (1995) Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II. Am J Hum Genet 56: 887–897.
Chen Y-T (2001) Glycogen storage disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 1521–1551.
Clavero S, Perez B, Rincon A, Ugarte M, Desviat LR (2004) Qualitative and quantitative analysis of the effect of splicing mutations in propionic acidemia underlying non-severe phenotypes. Hum Genet 115: 239–247.
Hermans MMP, van Leenen D, Kroos MA, Reuser AJJ (1997) Mutation detection in glycogen storage-disease type II by RT-PCR and automated sequencing. Biochem Biophys Res Commun 241: 414–418.
Hermans MMP, Kroos MA, Smeitink JAM, van der Ploeg AT, Kleijer WJ, Reuser AJJ (1998) Glycogen storage disease type II: genetic and biochemical analysis of novel mutations in infantile patients from Turkish ancestry. Hum Mutat 11: 209–215.
Hermans MM, van Leenen D, Kroos MA, et al (2004) Twenty-two novel mutations in the lysosomal alpha-glucosidase gene (GAA) underscore the genotype–phenotype correlation in glycogen storage disease type II. Hum Mutat 23: 47–56.
Hirschhorn R, Huie ML (1999) Frequency of mutations for glycogen storage disease type II in different populations: the delta525T and deltaexon 18 mutations are not generally “common” in white populations [letter; comment]. J Med Genet 36: 85–86.
Hirschhorn R, Reuser AJJ (2001) Glycogen storage disease type II (GSDII). In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Voglstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3389–3420.
Huie ML, Chen AS, Tsujino S, et al (1994) Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T->G) mutation in a majority of patients and a novel IVS10 (+1GT->CT) mutation. Hum Mol Genet 3: 2231–2236.
Kroos MA, van Leenen D, Verbiest J, Reuser AJ, Hermans MM (1998) Glycogen storage disease type II: identification of a dinucleotide deletion and a common missense mutation in the lysosomal alpha-glucosidase gene. Clin Genet 53: 379–382.
Michelakakis H, Mavridou I, Hermans M, Laskari H, Kourkouli M, Reuser A (2000) [Glycogen storage disease type II (Pompe's disease): new mutation in a Greek infant]. Paediatriki 63: 421–426.
Pipo JR, Feng JH, Yamamoto T, et al (2003) New GAA mutations in Japanese patients with GSDII (Pompe disease). Pediatr Neurol 29: 284–287.
Raben N, Nichols RC, Martiniuk F, Plotz PH (1996) A model of mRNA splicing in adult lysosomal storage disease (glycogenosis type II). Hum Mol Genet 5: 995–1000.
Reuser AJJ, Koster JF, Hoogeveen A, Galjaard H (1978) Biochemical, immunological, and cell genetic studies in glycogenosis type II. Am J Hum Genet 30: 132–143.
Reuser AJJ, Kroos MA, Hermans MMP, et al (1995) Glycogenosis type II (acid maltase deficiency). Muscle Nerve 3: S61–S69.
Swallow DM, Corney G, Harris H, Hirschhorn R (1975) Acid α-glucosidase: a new polymorphism in man demonstrable by ‘affinity’ electrophoresis. Ann Hum Genet 1975: 391–406.
Swallow DM, Kroos M, Van der Ploeg AT, et al (1989) An investigation of the properties and possible clinical significance of the lysosomal α-glucosidase GAA*2 allele. Ann Hum Genet 53: 177–184.
Teraoka SN, Telatar M, Becker-Catania S, et al (1999) Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. Am J Hum Genet 64: 1617–1631.
Vorgerd M, Burwinkel B, Reichmann H, Malin JP, Kilimann MW (1998) Adult-onset glycogen storage disease type II: phenotypic and allelic heterogeneity in German patients. Neurogenetics 1: 205–211.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: René Santer
Competing interests: None declared
http://www.pompecenter.nl/ http://www.fruitfly.org/seq tools/splice.html http://www.cbs.dtu.dk/services/NetGene2/ http://www.genet.sickkids.on.ca/~ali/splicesitefinder.html http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id = 232300
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Kroos, M., Manta, P., Mavridou, I. et al. Seven cases of Pompe disease from Greece. J Inherit Metab Dis 29, 556–563 (2006). https://doi.org/10.1007/s10545-006-0280-5
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10545-006-0280-5